ArticleNeurointervention2025
Early Complete Obliteration of Recurrent Large Basilar Aneurysm by Combined Use of Additional Woven EndoBridge Device and Flow Diverter: A Case Report.
Article in Neurointervention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 44-year-old female experienced a recurrence and enlargement of a basilar top aneurysm 2 years after initial treatment with a Woven EndoBridge (WEB) device. Retreatment using a new WEB device combined with a flow diverter (FD) via a semi-jail technique successfully obliterated the aneurysm without complications. Follow-up imaging at 4 months showed complete occlusion and favorable outcomes. This case suggests that combining WEB and FD may offer effective retreatment for complex, recurrent aneurysms, enhancing coverage and durability. Despite its technical challenges, this approach shows promise, though further long-term studies are needed to confirm its safety and wider applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.